United States — Food and Drug Administration & GenBioPro
2 shared events · Importance 3 · Last updated May 16, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
GenBioPro: GenBioPro, a manufacturer of a generic version of mifepristone, also filed an emergency appeal, contributing to the United States — Supreme Court of the United States's decision to restore access.
May 04, 2026 · 58 articles
Regulatory
GenBioPro: GenBioPro, a generic Mifepristone manufacturer, stated that the court's decision ignores the United States — Food and Drug Administration's science and decades of safe use of the drug.
May 01, 2026 · 78 articles
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and GenBioPro interact across events, view sentiment trends, and discover connected entities.
Open Dashboard